[Tumor suppressor RECK in prostate carcinoma. Decreased RECK expression as indicator of proteolytic imbalance].
Rabien
A
A
Klinik für Urologie, Charité--Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin. anja.rabien@charite.de
Jung
M
M
Fritzsche
F
F
Loening
S A
SA
Kristiansen
G
G
Jung
K
K
D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D058851:GPI-Linked Proteins; D016147:Genes, Tumor Suppressor; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics*; D009367:Neoplasm Staging; D010447:Peptide Hydrolases / Q000235:genetics*; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D020133:Reverse Transcriptase Polymerase Chain Reaction
D058851:GPI-Linked Proteins; D008562:Membrane Glycoproteins; C115460:RECK protein, human; D010447:Peptide Hydrolases